The Uromigos
The Uromigos
Broadcasting the latest developments in GU cancerHosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer CenterTom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Be sure to visit the podcast's website and support the creator: www.uromigos.org
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android almost 10M downloads · 4.8 rating
iOS soon
Episodes
Episode 35: Maintenance Avelumab in Bladder Cancer (LBA1) 31.05.2020 17:41
Dr. Kala Sridhar, Professor Tom Powles and Dr. Brian Rini discuss the data presented at ASCO.
Episode 34: Savolitinib in Renal Papillary Cancer - A Major Breakthrough? 30.05.2020 20:40
Dr. Toni Choueiri discusses the results of this study, which appears to show a survival signal, but it is difficult to interpret.
Episode 33: Adjuvant Atezolizumab in Urothelial Cancer 29.05.2020 19:59
Joaquim Bellmunt explains a bit about why this trial was not successful and what it means for the field.
Episode 32: A Phase 2 Study of PSMA PET in Prostate Cancer with Thomas Hope from ASCO 2020 29.05.2020 24:09
Thomas Hope is quizzed on the results of his study presented at ASCO20.
Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer 29.05.2020 25:18
Mike Atkins describes the results of this study which helps shed light on the role of ipilimumab and nivolumab in this disease.
Episode 30: Update on Axitinib plus Pembrolizumab in Renal Cancer (KEYNOTE 426) 29.05.2020 20:03
Betsy Plimack discusses the updated data with a minimum of 23 months' follow up. Dr. Brian Rini and Professor Tom Powles asks what it adds.
Episode 29: PSMA PET at ASCO 2020 with Mike Morris 29.05.2020 23:47
Mike Morris presents the findings in his prospective study.
Episode 28: Targeting VHL Syndrome Renal Cancer with a HIF Inhibitor - A Game Changer 29.05.2020 13:31
Eric Jonasch discusses his ASCO presentation, which shows significant activity of HIF targeting in renal cancer patients with VHL syndrome.
Episode 27: COVID-19 in > 1000 Cancer Patients with Jeremy Warner (CCC-19) 29.05.2020 21:44
Jeremy Warner summarises the recent Lancet paper describing the outcome of cancer patients with COVID-19.
Episode 26: Joaquim Bellmunt and Muscle Invasive Bladder Cancer prior to ASCO 2020 19.05.2020 22:23
Joaquim Bellmunt talks about management of muscle invasive bladder cancer prior to the Atezolizumab adjuvant data at ASCO20.
Episode 25: Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial 19.05.2020 14:47
Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial.
Episode 24: A Study of COVID-19 in Lung Cancer Shows High Mortality 28.04.2020 19:51
Marina Garassino and Leora Horn discuss their AACR study of COVID-19 in lung cancer.
Episode 23: Atezolizumab and Enzalutamide versus Enzalutamide Prostate Cancer 28.04.2020 22:35
Chris Sweeney explains why the trial was negative and answers some of the questions.
Episode 22: COVID-19 and Cardiovascular Disease 22.04.2020 18:28
Kaushik Amancherla and Javid Moslehi discuss the link of COVID-19 and cardiovascular disease. Professor Tom Powles and Dr. Brian Rini struggle to keep up.
Episode 21: Treating cancer patients over the next year in the era of COVID-19 15.04.2020 12:33
The Uromigos struggle to describe what cancer care looks like in three months’ time during the COVID-19 pandemic.
Episode 20: Treating GU Cancer Patients with acute COVID-19 Infection 15.04.2020 13:07
The Uromigos can’t agree on how to approach COVID-infected GU cancer patients who need systematic treatment.
Episode 19: Professor Monty Pal discusses the treatment of non-clear cell renal cancer 15.04.2020 18:17
Professor Monty Pal discusses non-clear cell renal cancer while Dr. Brian Rini gets irritated by background interruptions.
Episode 18: COVID-19: Addressing Renal Cancer Patients’ Concerns 06.04.2020 24:46
Dena Battle presents a 500-patient survey on issues around COVID-19. Professor Tom Powles and Dr. Brian Rini attempt to address the issues raised.
Episode 17: Dr. Toni Choueiri discusses cancer trials and meetings during COVID-19 02.04.2020 21:33
Professor Tom Powles, Dr. Brian Rini and Dr. Toni Choueiri discuss the evolving landscape in Boston, and meetings such as ASCO and ESMO in 2020.
Episode 16: Treatments and Trials for COVID-19 31.03.2020 25:31
Professor Nick Mark discusses the latest data on drug treatments and trials for COVID-19.
Episode 15: COVID-19 and Bladder Cancer Surgery 28.03.2020 14:52
The Uromigos discuss the practicalities in surgery for bladder cancer in the era of COVID-19 with Betsy Plimack (Fox Chase Cancer Center, Philadelphia)
Episode 14: A Discussion about Tocilizumab and COVID-19 with Dr. Nick Mark from Seattle 24.03.2020 15:04
Dr. Brian Rini and Professor Tom Powles discuss the data and ongoing studies with the IL-6 antibody tocilizumab.
Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials 23.03.2020 18:44
Dr. David Boulware discusses existing data and ongoing prophylaxis studies.
Episode 12: COVID-19 in Cancer Patients - The Seattle Experience 20.03.2020 26:19
A discussion with doctors from the Fred Hutchinson Cancer Center in Seattle about COVID-19.
Episode 11: COVID-19 and Immune Checkpoint Inhibitors for the Treatment of Cancer 16.03.2020 17:43
Chuck Drake and Doug Johnson discuss possible risk benefits of immune checkpoint inhibitors during the COVID-19 pandemic.
Similar podcasts
Listen to the The Uromigos podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
